Cargando…
Androgen Activity Is Associated With PD-L1 Downregulation in Thyroid Cancer
Thyroid cancer is the most prevalent endocrine malignancy in the United States with greater than 53,000 new cases in 2020. There is a significant gender disparity in disease incidence as well, with women developing thyroid cancer three times more often than men; however, the underlying cause of this...
Autores principales: | O’Connell, Timmy J., Dadafarin, Sina, Jones, Melanie, Rodríguez, Tomás, Gupta, Anvita, Shin, Edward, Moscatello, Augustine, Iacob, Codrin, Islam, Humayun, Tiwari, Raj K., Geliebter, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377372/ https://www.ncbi.nlm.nih.gov/pubmed/34422798 http://dx.doi.org/10.3389/fcell.2021.663130 |
Ejemplares similares
-
Androgen Receptor Activation Induces Senescence in Thyroid Cancer Cells
por: Gupta, Anvita, et al.
Publicado: (2023) -
MEG3 Expression Indicates Lymph Node Metastasis and Presence of Cancer-Associated Fibroblasts in Papillary Thyroid Cancer
por: Dadafarin, Sina, et al.
Publicado: (2022) -
Gene master regulators of papillary and anaplastic thyroid cancers
por: Iacobas, Dumitru A., et al.
Publicado: (2017) -
Hyperactive ERK and persistent mTOR signaling characterize vemurafenib resistance in papillary thyroid cancer cells
por: Hanly, Elyse K., et al.
Publicado: (2015) -
The epigenetic function of androgen receptor in prostate cancer progression
por: Sawada, Takahiro, et al.
Publicado: (2023)